Mark Bosbous
Plastic Surgery · Milwaukee, WINPI 1033203906
Payments from drug & device makers
What this record shows
7 manufacturers reported payments, led by Integra Lifesciences Corporation at 58.8% of the total. Reporting peaked in 2024 at $1,116 and has fallen 69.6% since, to $340 in 2025.
Across 17 payments — averaging $97.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$977
- Musculoskeletal Transplant Foundation Inc.$278
- Mentor Worldwide LLC$216
- Kls-martin L.p.$119
- Johnson & Johnson$41
- Endo Pharmaceuticals Inc.$18
- plus $14 from 1 others
What the payments were for
- Food & beverage$68641%
- Other$97759%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 2 | $977 |
| Musculoskeletal Transplant Foundation Inc. | 4 | $278 |
| Mentor Worldwide LLC | 6 | $216 |
| Kls-martin L.p. | 2 | $119 |
| Johnson & Johnson | 1 | $41 |
| Endo Pharmaceuticals Inc. | 1 | $18 |
| Acera Surgical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,663 in reported general payments places this provider in the 60th percentile of 77 plastic surgery providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 36 | $206 |
| Cephalexin | 29 | $171 |
| Oxycodone Hcl | 15 | $57 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $49 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Milwaukee
- Aaron MorganMilwaukee$39K
- Nyama SillahMilwaukee$19K
- Roger MixterMilwaukee$12K
- Lucas BoehmMilwaukee$8K
- Mark BlakeMilwaukee$6K
- Sameer ShakirMilwaukee$5K
- John LogiudiceMilwaukee$4K
- Gwendolyn HobenMilwaukee$1K
- Kate KrucoffMilwaukee$973
- Megan PencekMilwaukee$820
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.